New Key Statistics Module, Z-Score and F-Score
NAS:IONS Key Ratios
| Market Cap $ M | 5,283.24 |
| Enterprise Value $ M | 4,246.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.97 |
| Price/Sales | 6.06 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 803.00 |
| EPS (TTM) $ | -2.44 |
| Beneish M-Score | -3.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -15.71 |
| EV-to-EBITDA | -17.12 |
| PEG | -- |
| Shares Outstanding M | 157.90 |
| Net Margin (%) | -44.68 |
| Operating Margin % | -46.12 |
| Pre-tax Margin (%) | -44.31 |
| Quick Ratio | 8.82 |
| Current Ratio | 8.91 |
| ROA % (ttm) | -12.41 |
| ROE % (ttm) | -93.21 |
| ROIC % (ttm) | -65.41 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.25 |
IONS Number of Guru Trades
IONS Volume of Guru Trades
Gurus Latest Trades with NAS:IONS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IONS is held by these investors
Total 4
Ionis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IONS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers